Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
AKKERMANSIA MUCINIPHILA EB-AMDK19 STRAIN AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2021/040187
Kind Code:
A1
Abstract:
Disclosed are a novel Akkermansia muciniphila strain having the effect of preventing or treating inflammatory disease or metabolic disease, and a pharmaceutical composition effective for preventing or treating inflammatory disease or metabolic disease, which contains the strain or a culture thereof. While traditional probiotics generally have insufficient therapeutic effects on inflammatory or metabolic diseases, the disclosed next-generation probiotic strain has an excellent effect on the prevention or treatment of inflammatory disease and/or metabolic disease so that it may be used as a new prophylactic and therapeutic tool.

Inventors:
SEO JAE-GU (KR)
SHIN JOO-HYUN (KR)
LEE DO-KYUNG (KR)
Application Number:
PCT/KR2020/006179
Publication Date:
March 04, 2021
Filing Date:
May 11, 2020
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
ENTEROBIOME INC (KR)
International Classes:
C12N1/20; A23L33/135; A61K35/74; A61P3/00; A61P29/00; C12R1/01
Foreign References:
KR20150093711A2015-08-18
KR20150133646A2015-11-30
KR101809172B12017-12-14
KR20130021920A2013-03-06
Other References:
DATABASE PROTEIN 11 December 2013 (2013-12-11), "carboxyl-terminal protease [Akkermansia muciniphila ATCC BAA-835]", XP055785809, retrieved from NCBI Database accession no. ACD05451
Attorney, Agent or Firm:
KIM, Hak Je et al. (KR)
Download PDF: